BPH GlobalASX:BP8 +100.00% Operating Margin % is -72.31% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, BPH Global ranks worse than 92.15% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. BPH Global's Operating Income for the
six
months ended in Dec. 2025 was A$-1.00 Mil. BPH Global's Revenue for the
six
months ended in Dec. 2025 was A$1.38 Mil. Therefore, BPH Global's Operating Margin % for the quarter that ended in Dec. 2025 was -72.31%.
The historical rank and industry rank for BPH Global's Operating Margin % or its related term are showing as below:
ASX:BP8'
s Operating Margin % Range Over the Past 10 Years
Min: -3771.88 Med: -383.24 Max: -20.57
Current: -112.76
ASX:BP8's Operating Margin % is ranked worse than 92.15% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs ASX:BP8: -112.76
BPH Global's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
BPH Global's Operating Income for the
six
months ended in Dec. 2025 was A$-1.00 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.89 Mil.
Warning Sign:
BPH Global Ltd has never been profitable in the past 3 years. It lost money every year.
BPH Global (ASX:BP8) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
BPH Global Operating Margin % Related Terms
BPH Global Operating Margin % Historical Data
* Premium members only.
The historical data trend for BPH Global's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BPH Global Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BPH Global's Operating Margin % distribution charts can be found below:
* The bar in red indicates where BPH Global's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
BPH Global's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BPH Global (ASX:BP8) has a Operating Margin % of -72.31% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on BPH Global and its competitors. According to the industry distribution chart, BPH Global ranks #880 out of 955 companies in the Drug Manufacturers industry, placing it in the top 92.1%.
Is BPH Global's Operating Margin % too high?
BPH Global's current Operating Margin % is -72.31%. Based on the distribution chart, BPH Global ranks #880 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does BPH Global's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BPH Global ranks #880 out of 955 companies for Operating Margin %. This places BPH Global in the lower half of its industry. The industry median Operating Margin % is 7.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on BPH Global and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BPH Global's current Operating Margin % is -72.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current Operating Margin % of -72.31%. The current Operating Margin % is -72.31%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current Operating Margin % is -72.31% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BP8 has been successfully added to your 